The effect of professional-led guideline workshops on clinical practice for the management of patent ductus arteriosus in preterm neonates in Japan: a controlled before-and-after study
- PMID: 25952042
- PMCID: PMC4438511
- DOI: 10.1186/s13012-015-0258-5
The effect of professional-led guideline workshops on clinical practice for the management of patent ductus arteriosus in preterm neonates in Japan: a controlled before-and-after study
Abstract
Background: Clinical guidelines assist physicians to make decisions about suitable healthcare. We conducted a controlled before-and-after study to investigate the impact of professional-led guideline workshops for patent ductus arteriosus (PDA) management on physicians' clinical practices, discharge mortality, and associated morbid conditions among preterm neonates.
Methods: We recruited physicians practicing at two neonatal intensive care units (NICUs) in Japan and used the data of all neonates weighing less than or equal to 1,500 g admitted to 90 NICUs (2 intervention NICUs and 88 control NICUs) in the Neonatal Research Network of Japan from April 2008 to March 2010. We held 1-day workshops for physicians on PDA clinical practice guidelines at the two intervention NICUs. Physicians' skills assessed by confidence rating (CR) scores and the Sheffield Peer Review Assessment Tool (SPRAT) were compared between pre- and post-workshop month at the intervention NICUs using Wilcoxon signed-rank tests. Neonatal discharge mortality and morbidity were compared between pre- and post-workshop year at both the intervention and control NICUs using multivariable regression analyses adjusting for potential confounders.
Results: Fifteen physicians were included in the study. Physicians' CR scores (2.14 vs. 2.47, p = 0.02) and SPRAT (4.14 vs. 4.50, p = 0.05) in PDA management improved after the workshops. The analyses of neonatal outcomes included 294 and 6,234 neonates in the intervention and control NICUs, respectively. Neonates' discharge mortality declined sharply at the intervention NICUs (from 15/146 to 5/148, relative risk reduction -0.67; adjusted odds ratio 0.30, 95% confidence interval 0.10 to 0.89) during the post-workshop period. The mortality reduction was much greater than that in the control NICUs (from 207/3,322 to 147/2,912, relative risk reduction -0.19; adjusted odds ratio 0.75, 95% confidence interval 0.59 to 0.95), although the difference between the intervention and control NICUs were not statistically significant.
Conclusions: Overall, physicians' confidence in PDA management improved after attending guideline workshops. Face-to-face workshops by guideline developers can be a useful strategy to improve physicians' PDA management skills and, thereby, might reduce PDA-associated mortality in preterm neonates.
Figures
Similar articles
-
Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns.J Matern Fetal Neonatal Med. 2009;22 Suppl 3:77-80. doi: 10.1080/14767050903198314. J Matern Fetal Neonatal Med. 2009. PMID: 19925365
-
Hospital variation in medical and surgical treatment of patent ductus arteriosus.Am J Perinatol. 2015 Mar;32(4):379-86. doi: 10.1055/s-0034-1387931. Epub 2014 Sep 21. Am J Perinatol. 2015. PMID: 25241108
-
Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias.J Pediatr. 2012 Oct;161(4):689-94.e1. doi: 10.1016/j.jpeds.2012.05.007. Epub 2012 Jun 14. J Pediatr. 2012. PMID: 22703954
-
[Progress in management of patent ductus arterious in preterm infants with gestational age of <28 weeks].Zhongguo Dang Dai Er Ke Za Zhi. 2015 Oct;17(10):1142-7. Zhongguo Dang Dai Er Ke Za Zhi. 2015. PMID: 26483241 Review. Chinese.
-
Management of patent ductus arteriosus in preterm infants--where do we stand?Congenit Heart Dis. 2013 Nov-Dec;8(6):500-12. doi: 10.1111/chd.12143. Epub 2013 Oct 15. Congenit Heart Dis. 2013. PMID: 24127861 Review.
Cited by
-
Correlation between the Closure Time of Patent Ductus Arteriosus in Preterm Infants and Long-Term Neurodevelopmental Outcome.J Cardiovasc Dev Dis. 2024 Jan 16;11(1):26. doi: 10.3390/jcdd11010026. J Cardiovasc Dev Dis. 2024. PMID: 38248896 Free PMC article.
-
Revisions of clinical protocols using the Plan Do Check Act cycle improved outcomes of extremely preterm infants at 2 years.Acta Paediatr. 2021 Jul;110(7):2100-2109. doi: 10.1111/apa.15840. Epub 2021 Mar 25. Acta Paediatr. 2021. PMID: 33711173 Free PMC article.
References
-
- The Investigators of the Vermont-Oxford Trials Network Database Project The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Investigators of the Vermont-Oxford Trials Network Database Project. Pediatrics. 1993;91:540–5. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous